Clinical Trial Update: The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effect of empagliflozin on nonalcoholic fatty liver disease in Asian patients with type 2 diabetes; current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: University of Malaya | Conditions: Type2 Diabetes, NAFLD | Phase 4 | Status: UNKNOWN